Treatment of Type 2 diabetic nephropathy mice with the sodium-glucose cotransporter-2 inhibitor (SGLT2i) and/or angiotensin receptor blocker (ARB) Liao, Zhouning 2024 - E-Dissertationen der UHH - frei zugänglich
